ALDX Investor Alert: Robbins LLP Urges Investors to Contact the Firm for Information about the Upcoming Lead Plaintiff Deadline in Aldeyra Therapeutics, Inc. Class Action Lawsuit SAN DIEGO, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired Aldeyra (NASDAQ: ALDX)...

ALDX Stock News: Shareholders with Significant Losses in Aldeyra Therapeutics, Inc. Should Contact Robbins LLP SAN DIEGO, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired Aldeyra (NASDAQ: ALDX)...

Aldeyra Therapeutics, Inc. (ALDX) Shareholder Notice: Robbins LLP Reminds Shareholders of Class Action Filed Against Aldeyra Therapeutics, Inc. SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of investors who purchased or otherwise acquired Aldeyra (NASDAQ: ALDX)...